• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有脏层胸膜侵犯的病理I期肺腺癌的复发模式

Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.

作者信息

Jiwangga Dhihintia, Cho Sukki, Kim Kwhanmien, Jheon Sanghoon

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul, Korea.

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul, Korea; Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Ann Thorac Surg. 2017 Apr;103(4):1126-1131. doi: 10.1016/j.athoracsur.2016.09.052. Epub 2016 Dec 16.

DOI:10.1016/j.athoracsur.2016.09.052
PMID:27993377
Abstract

BACKGROUND

Visceral pleural invasion (VPI) is well known to be a poor prognostic factor in lung adenocarcinoma. There were few studies reporting postoperative recurrence pattern in lung adenocarcinoma with VPI. This study was to evaluate the clinical effect of VPI on recurrence pattern in pathologic stage I lung adenocarcinoma after curative resection.

METHODS

Among 574 patients with pathologic stage I lung adenocarcinoma after complete resection between 2003 and 2012, the clinicopathologic characteristics of 89 patients (16%) who had recurrence were retrospectively reviewed. The pathologic findings, postrecurrence survival, and patterns of recurrence were compared between patients with VPI and without VPI.

RESULTS

Median follow-up duration was 53.6 months. The VPI was found in 43 patients (group I) and not found in 46 patients (group II). Both total tumor size and invasive size were larger in group I (3.2 versus 2.7 cm and 2.5 versus 2.1 cm; p < 0.05). The median duration of overall survival was 58 months in group I and 76 months in group II. As patterns of recurrence, pleural seeding was found in 25 patients, and the percentage of pleural seeding was significantly higher in group I than group II (44.2% versus 13.0%; p = 0.001). In group I, bilateral lung metastasis was significantly common (39.5% versus 13.0%; p = 0.004), and increasing percentage of pleural seeding was observed as the invasive tumor size grows.

CONCLUSIONS

The presence of VPI was a significant predictable factor for pleural seeding and bilateral lung metastasis as patterns of recurrence after complete resection in pathologic stage I lung adenocarcinoma.

摘要

背景

众所周知,脏层胸膜侵犯(VPI)是肺腺癌预后不良的因素。关于伴有VPI的肺腺癌术后复发模式的研究较少。本研究旨在评估VPI对I期肺腺癌根治性切除术后复发模式的临床影响。

方法

回顾性分析2003年至2012年间574例I期肺腺癌根治性切除患者的临床病理特征,其中89例(16%)出现复发。比较有VPI和无VPI患者的病理结果、复发后生存率和复发模式。

结果

中位随访时间为53.6个月。43例患者(I组)发现有VPI,46例患者(II组)未发现。I组的肿瘤总体大小和浸润大小均更大(分别为3.2对2.7 cm和2.5对2.1 cm;p<0.05)。I组的总生存期中位数为58个月,II组为76个月。作为复发模式,25例患者出现胸膜播散,I组胸膜播散的比例显著高于II组(44.2%对13.0%;p=0.001)。在I组中,双侧肺转移显著常见(39.5%对13.0%;p=0.004),并且随着浸润肿瘤大小的增加,胸膜播散的比例也在增加。

结论

VPI的存在是I期肺腺癌根治性切除术后胸膜播散和双侧肺转移这两种复发模式的重要预测因素。

相似文献

1
Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.伴有脏层胸膜侵犯的病理I期肺腺癌的复发模式
Ann Thorac Surg. 2017 Apr;103(4):1126-1131. doi: 10.1016/j.athoracsur.2016.09.052. Epub 2016 Dec 16.
2
[Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].[肿瘤大小≤3cm的肺腺癌脏层胸膜侵犯的预后研究]
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):553-558. doi: 10.3760/cma.j.issn.0529-5807.2017.08.007.
3
Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.脏层胸膜侵犯是直径30mm及以下的部分实性肺腺癌患者的一个重要预后因素。
Thorac Cardiovasc Surg. 2018 Mar;66(2):150-155. doi: 10.1055/s-0036-1586757. Epub 2016 Aug 12.
4
Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.在肿瘤直径为 2cm 或以下且无区域淋巴结转移(pN0)的非小细胞肺癌患者中,脉管侵犯与脏层胸膜侵犯的预后影响比较。
J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.
5
Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.内脏胸膜侵犯并不影响≤2cm 肺腺癌患者的复发或总生存:肺腺癌 T1 再分类的建议。
Chest. 2013 Nov;144(5):1622-1631. doi: 10.1378/chest.13-0394.
6
The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.非贴壁生长型的病理浸润成分大小在Ⅰ期肺腺癌中的预后作用。
J Thorac Cardiovasc Surg. 2013 Sep;146(3):580-5. doi: 10.1016/j.jtcvs.2013.04.032. Epub 2013 Jun 15.
7
[Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].[脏层胸膜侵犯对Ⅰb期非小细胞肺癌预后的影响]
Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):368-71.
8
Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.非小细胞肺癌侵犯脏层胸膜:一个被低估的不良预后因素。
Ann Thorac Surg. 2001 Apr;71(4):1088-93. doi: 10.1016/s0003-4975(00)02649-7.
9
Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.手术切除的 I 期非小细胞肺癌中淋巴管血管侵犯和内脏胸膜侵犯的预后影响和初始复发部位。
Eur J Cardiothorac Surg. 2013 Sep;44(3):e200-6. doi: 10.1093/ejcts/ezt309. Epub 2013 Jun 13.
10
Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.内脏胸膜侵犯并不预示着肺癌患者和较小肿瘤大小的生存情况。
Ann Thorac Surg. 2013 Jun;95(6):1872-7; discussion 1877. doi: 10.1016/j.athoracsur.2013.03.085. Epub 2013 May 2.

引用本文的文献

1
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis.切除性浸润性黏液性腺癌的预后因素:系统评价和荟萃分析。
BMC Cancer. 2024 Oct 25;24(1):1317. doi: 10.1186/s12885-024-13068-x.
2
The prognostic value of lymphovascular invasion for stage I lung adenocarcinoma based on the presence of ground-glass opacity.基于磨玻璃影存在情况的Ⅰ期肺腺癌中淋巴管侵犯的预后价值
Eur Radiol. 2025 Apr;35(4):2256-2264. doi: 10.1007/s00330-024-11048-0. Epub 2024 Sep 16.
3
Preoperative evaluation of visceral pleural invasion in peripheral lung cancer utilizing deep learning technology.
利用深度学习技术对周围型肺癌脏层胸膜侵犯进行术前评估。
Surg Today. 2025 Jan;55(1):18-28. doi: 10.1007/s00595-024-02869-z. Epub 2024 May 23.
4
The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study.I期非小细胞肺癌中高风险临床病理特征对化疗的价值:一项倾向评分匹配研究。
J Thorac Dis. 2024 Mar 29;16(3):2125-2141. doi: 10.21037/jtd-24-305. Epub 2024 Mar 27.
5
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review.预测肺癌脏层胸膜侵犯的研究进展:一项叙述性综述
Transl Cancer Res. 2024 Jan 31;13(1):462-470. doi: 10.21037/tcr-23-1318. Epub 2023 Dec 26.
6
Prognostic Impact of Visceral Pleural Invasion in Resected Solitary Lung Metastases from Gastric Cancer.胃腺癌单发肺转移瘤切除术后内脏胸膜侵犯的预后影响。
Ann Thorac Cardiovasc Surg. 2023 Dec 20;29(6):279-286. doi: 10.5761/atcs.oa.23-00032. Epub 2023 Jun 13.
7
The effects of the degree of pleural invasion on survival in patients with non-small cell lung cancer undergoing surgical resection.胸膜侵犯程度对接受手术切除的非小细胞肺癌患者生存的影响。
Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Oct 31;30(4):602-610. doi: 10.5606/tgkdc.dergisi.2022.22154. eCollection 2022 Oct.
8
A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis.一种靶向 PD-L1 的嵌合开关受体增强了 CAR-T 细胞治疗胸膜和腹膜转移的疗效。
Signal Transduct Target Ther. 2022 Nov 19;7(1):380. doi: 10.1038/s41392-022-01198-2.
9
Rethinking the Selection of Pathological T-Classification for Non-Small-Cell Lung Cancer in Varying Degrees of Visceral Pleural Invasion: A SEER-Based Study.重新思考不同程度脏层胸膜侵犯的非小细胞肺癌病理T分类的选择:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Surg. 2022 May 19;9:902710. doi: 10.3389/fsurg.2022.902710. eCollection 2022.
10
The prognostic analysis of lung cancer patients with occult malignant pleural disease at thoracotomy.开胸手术时伴有隐匿性恶性胸膜疾病的肺癌患者的预后分析
Transl Cancer Res. 2020 Mar;9(3):1689-1697. doi: 10.21037/tcr.2020.02.03.